Kevin Puylaert's guest appearances

Kevin Puylaert

Finding Genius Podcast

FutureTech Podcast

J Scott

Danny Flood

Perry Marshall

Ross Taylor

Mark Bertin

Elisha Goldstein

Scott Nelson

Robin Smith

Cassie Bjork

Andreas Eenfeldt

Hannah Crum

Naveen Jain

Andrew Walker

Eric Boduch

Alex Lewin

OwlTail

Approximately 15,000 new genomic profiles are analyzed on the SOPHiA GENETICS platform every month, and nearly 1,000 institutions are sharing and comparing this information for the ultimate goal of better understanding the relationship between genes and cancer and rare disorders, coming up with prognostic information, and identifying the best treatments in light of a patient’s genetic profile. General manager of North American operations and VP of business development at SOPHiA GENETICS, Kevin Puylaert, offers a glimpse into a world where massive amounts of data are being collected and analyzed on a regular basis for the betterment of data-driven medicine. He also discusses the details of the work they’re doing and what’s on the horizon in the coming months and years. Press play for all the details and check out https://www.sophiagenetics.com/en_US/home.html to learn more.

Approximately 15,000 new genomic profiles are analyzed on the SOPHiA GENETICS platform every month, and nearly 1,000 institutions are sharing and comparing this information for the ultimate goal of better understanding the relationship between genes and cancer and rare disorders, coming up with prognostic information, and identifying the best treatments in light of a patient’s genetic profile. General manager of North American operations and VP of business development at SOPHiA GENETICS, Kevin Puylaert, offers a glimpse into a world where massive amounts of data are being collected and analyzed on a regular basis for the betterment of data-driven medicine. He also discusses the details of the work they’re doing and what’s on the horizon in the coming months and years. Press play for all the details and check out <a href="https://www.sophiagenetics.com/en_US/home.html" rel="nofollow" target="_blank">https://www.sophiagenetics.com/en_US/home.html</a> to learn more.

Amassing and Standardizing Genomic Data for Useful Comparisons in Data-Driven Medicine—Kevin Puylaert—SOPHiA GENETICS

Kevin Puylaert is general manager of North American operations and VP of business development at SOPHiA GENETICS, a company that’s offering software as a service platform for the democratization of data-driven medicine. They have already connected nearly 1,000 institutions that are sharing genomic profiles across the platform, which means any given institution that’s analyzing a genetic profile can easily determine how it compares to another institution’s analysis of that profile somewhere else in the world.   To date, they’ve looked at over 300,000 profiles, and they see about 15,000 more profiles analyzed through the platform on a monthly basis. Puylaert joins the podcast to discuss how their platform sifts through the noise often found in genetic data and standardizes the way data is generated in order to allow researchers from a variety of places to make comparisons. He explains the type of research they’re helping to advance, which includes determining whether certain genes are associated with cancer, procuring prognostic information based on a variety of DNA and RNA samples, and recommending certain treatments for patients. He also discusses the other types of work they’re doing to get closer to a system of data-driven medicine.   Tune in to hear the full conversation and visit https://www.sophiagenetics.com/en_US/home.html to learn more.

Kevin Puylaert is general manager of North American operations and VP of business development at SOPHiA GENETICS, a company that’s offering software as a service platform for the democratization of data-driven medicine. They have already connected nearly 1,000 institutions that are sharing genomic profiles across the platform, which means any given institution that’s analyzing a genetic profile can easily determine how it compares to another institution’s analysis of that profile somewhere else in the world. To date, they’ve looked at over 300,000 profiles, and they see about 15,000 more profiles analyzed through the platform on a monthly basis. Puylaert joins the podcast to discuss how their platform sifts through the noise often found in genetic data and standardizes the way data is generated in order to allow researchers from a variety of places to make comparisons. He explains the type of research they’re helping to advance, which includes determining whether certain genes are associated with cancer, procuring prognostic information based on a variety of DNA and RNA samples, and recommending certain treatments for patients. He also discusses the other types of work they’re doing to get closer to a system of data-driven medicine. Tune in to hear the full conversation and visit <a href="https://www.sophiagenetics.com/en_US/home.html" rel="nofollow" target="_blank">https://www.sophiagenetics.com/en_US/home.html</a> to learn more.

Increasing Access to Genomic Data and Driving Data-Driven Medicine—Kevin Puylaert—SOPHiA GENETICS